Terms: = Skin cancer AND MYCN, N-myc, 4613, ENSG00000134323, NMYC, MODED, ODED AND Treatment
15 results:
1. Ceftriaxone exerts antitumor effects in mycn-driven retinoblastoma and neuroblastoma by targeting DDX3X for translation repression.
Chittavanich P; Saengwimol D; Roytrakul S; Rojanaporn D; Chaitankar V; Srimongkol A; Anurathapan U; Hongeng S; Kaewkhaw R
Mol Oncol; 2024 Apr; 18(4):918-938. PubMed ID: 37975412
[TBL] [Abstract] [Full Text] [Related]
2. Neuroblastoma in a Neonate: A Case Report.
Jnah AJ; Evans SK; Sewell K; Trembath A
Neonatal Netw; 2019 Nov; 38(6):341-347. PubMed ID: 31712398
[TBL] [Abstract] [Full Text] [Related]
3. The hematopoietic stem cell regulatory gene latexin has tumor-suppressive properties in malignant melanoma.
Muthusamy V; Premi S; Soper C; Platt J; Bosenberg M
J Invest Dermatol; 2013 Jul; 133(7):1827-33. PubMed ID: 23364479
[TBL] [Abstract] [Full Text] [Related]
4. Is the prognosis of stage 4s neuroblastoma in patients 12 months of age and older really excellent?
Iehara T; Hiyama E; Tajiri T; Yoneda A; Hamazaki M; Fukuzawa M; Hosoi H; Sugimoto T; Sawada T
Eur J Cancer; 2012 Jul; 48(11):1707-12. PubMed ID: 22305511
[TBL] [Abstract] [Full Text] [Related]
5. Metastatic uveal melanoma: is there a role for conventional chemotherapy? - A single center study based on 58 patients.
Pons F; Plana M; Caminal JM; Pera J; Fernandes I; Perez J; Garcia-Del-Muro X; Marcoval J; Penin R; Fabra A; Piulats JM
Melanoma Res; 2011 Jun; 21(3):217-22. PubMed ID: 21467954
[TBL] [Abstract] [Full Text] [Related]
6. A focal lesion in the falx cerebri: Harbinger of classic stage 4 neuroblastoma in an infant cured despite residual disease after minimal therapy.
Kushner BH; Kramer K; Modak S; Akhurst TJ; Cheung NK
Pediatr Blood Cancer; 2009 Dec; 53(7):1340-2. PubMed ID: 19711437
[TBL] [Abstract] [Full Text] [Related]
7. [4S neuroblastoma with bilateral adrenal tumors].
Kerdudo C; Corradini N; Michon J; Leverger G
Arch Pediatr; 2004 Dec; 11(12):1450-6. PubMed ID: 15596333
[TBL] [Abstract] [Full Text] [Related]
8. Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: a Children's cancer Group study.
Nickerson HJ; Matthay KK; Seeger RC; Brodeur GM; Shimada H; Perez C; Atkinson JB; Selch M; Gerbing RB; Stram DO; Lukens J
J Clin Oncol; 2000 Feb; 18(3):477-86. PubMed ID: 10653863
[TBL] [Abstract] [Full Text] [Related]
9. Neuroblastoma 4S: a heterogeneous disease with variable risk factors and treatment strategies.
van Noesel MM; Hählen K; Hakvoort-Cammel FG; Egeler RM
Cancer; 1997 Sep; 80(5):834-43. PubMed ID: 9307181
[TBL] [Abstract] [Full Text] [Related]
10. A metastatic neuroblastoma model in SCID mice.
Bogenmann E
Int J Cancer; 1996 Jul; 67(3):379-85. PubMed ID: 8707412
[TBL] [Abstract] [Full Text] [Related]
11. Regression and progression in neuroblastoma. Does genetics predict tumour behaviour?
Ambros PF; Ambros IM; Strehl S; Bauer S; Luegmayr A; Kovar H; Ladenstein R; Fink FM; Horcher E; Printz G
Eur J Cancer; 1995; 31A(4):510-5. PubMed ID: 7576955
[TBL] [Abstract] [Full Text] [Related]
12. [Neuroblastoma IV-S. A multicenter study. Work Group of Pediatric Oncology. Spanish Society of Pediatric Surgery].
Rollán Villamarín V; García Aroca J; Costa Borrás E; Cuadros García J; Jiménez Alvarez C; Martínez-Caro A; Martínez Ibáñez V; Mulet Ferragut F; Obiols Arderius P; Pérez La Fuente G
Cir Pediatr; 1994 Oct; 7(4):167-70. PubMed ID: 7865360
[TBL] [Abstract] [Full Text] [Related]
13. Modulation of POMC expression in human neuroectodermal cells.
De Laurenzi V; Melino G; Knight RA; Pierotti AR; Cohen P
Biochem Biophys Res Commun; 1993 Dec; 197(3):1402-9. PubMed ID: 8280157
[TBL] [Abstract] [Full Text] [Related]
14. Paratesticular neuroblastoma with n-myc activation.
Matsunaga T; Takahashi H; Ohnuma N; Tanabe M; Yoshida H; Enomoto H; Horie H; Shirasawa H; Simizu B
J Pediatr Surg; 1993 Dec; 28(12):1612-4. PubMed ID: 8301510
[TBL] [Abstract] [Full Text] [Related]
15. Neuroblastoma stage IV-S: a heterogeneous disease.
Wilson PC; Coppes MJ; Solh H; Chan HS; Jenkin D; Greenberg ML; Weitzman S
Med Pediatr Oncol; 1991; 19(6):467-72. PubMed ID: 1961133
[TBL] [Abstract] [Full Text] [Related]
